DIAMIR LLC has a total of 32 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are GENDIAG EXE SL, ONCOMETHYLOME SCIENCES S A and GU JIERUO.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | China | 4 | |
#6 | Australia | 3 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Sheinerman Kira S | 29 |
#2 | Umansky Samuil R | 27 |
#3 | Tsivinsky Vladimir | 15 |
#4 | Tsivinsky Vladimir G | 12 |
#5 | Umansky Samuil | 3 |
#6 | Sheinerman Kirsa S | 2 |
#7 | Kira S Sheinerman | 1 |
#8 | Samuil R Umansky | 1 |
#9 | Vladimir Tsivinsky | 1 |
#10 | Umanksy Samuil R | 1 |
Publication | Filing date | Title |
---|---|---|
US2019024169A1 | miRNA-based methods for detecting and monitoring aging | |
US2018312925A1 | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders | |
EP3433381A1 | Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases | |
WO2017120285A1 | METHODS OF USING miRNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEVELOPMENTAL DISORDERS | |
US2016273043A1 | Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd) | |
AU2012245580A1 | miRNA-based universal screening test (UST) | |
EP2496714A2 | Methods of using micro-rna from bodily fluids for diagnosis and monitoring of mild cognitive impairment |